机构

• 上海药物研究所 [5]
• 新疆理化技术研究所 [1]
• 上海营养与健康研究所 [1]
• 生态环境研究中心 [1]

采集方式

• OAI收割 [8]

内容类型

• 期刊论文 [8]

发表日期

• 2022 [3]
• 2018 [1]
• 2017 [3]
• 2016 [1]

学科主题

• Biochemist... [1]
• Chemistry [1]
• Pharmacolo... [1]

筛选

浏览/检索结果: 共8条，第1-8条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Alteration of intestinal microecology by oral antibiotics promotes oral squamous cell carcinoma development 期刊论文  OAI收割 MOLECULAR IMMUNOLOGY, 2022, 卷号: 149, 期号: 0, 页码: 94-106 作者:  Wei, Wei;  Li, Jia;  Liu, Fan;  Wu, Miaomiao;  Xiong, Kaixin   |  收藏  |  浏览/下载：28/0  |  提交时间：2022/11/09 CANCER  TYROSINE  METABOLISM  OPPORTUNITIES  NECROPTOSIS  MICROBIOME  DISEASE  VACCINE  HEAD   Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 卷号: 23, 期号: 9, 页码: 14 作者:  Wang, Jiyan;  Chang, Hongkai;  Su, Meng;  Qiao, Yaya;  Sun, Huanran   |  收藏  |  浏览/下载：32/0  |  提交时间：2022/08/16 tyrosine metabolism  fumarate  metabolism reprogramming  renal cell carcinoma   Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma 期刊论文  OAI收割 BIOMEDICINES, 2022, 卷号: 10, 期号: 2, 页码: 14 作者:  Wang, Jiyan;  Qiao, Yaya;  Sun, Huanran;  Chang, Hongkai;  Zhao, Huifang   |  收藏  |  浏览/下载：38/0  |  提交时间：2022/06/15 hepatocellular carcinoma  tyrosine metabolism  lipids synthesis  cell cycle   Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 6, 页码: 1048-1063 作者:  Zhong, Chen-chun;  Chen, Feng;  Yang, Jun-ling;  Jia, Wei-wei;  Li, Li   |  收藏  |  浏览/下载：51/0  |  提交时间：2019/01/08 anlotinib  tyrosine kinase inhibitor  absorption  distribution  metabolism  excretion  pharmacokinetics   Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 卷号: 110, 页码: 51-61 作者:  Li, Xin;  Yang, Changyong;  Wan, Hong;  Zhang, Ge;  Feng, Jun   |  收藏  |  浏览/下载：148/0  |  提交时间：2019/01/08 Pyrotinib  HER2-postive breast cancer  Irreversible EGFR/HER2 dual tyrosine kinase  inhibitor  Preclinical  Clinical  Safety  Drug metabolism   Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanism via PI3K/Akt signaling pathway 期刊论文  OAI收割 BIOMEDICINE & PHARMACOTHERAPY, 2017, 卷号: 87, 期号: 3, 页码: 145-152 作者:  Tang, D (Tang, Dan);  Chen, QB (Chen, Qi-Bin);  Xin, XL (Xin, Xue-Lei);  Aisa, HA (Aisa, Haji-Akber);  Aisa, HA 收藏  |  浏览/下载：21/0  |  提交时间：2017/04/05 Diabetes  Norditerpenoid alkaloids  Anti-diabetic activity  Glucose metabolism  Protein tyrosine phosphatase 1B  PI3K/Akt signaling pathway   Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma 期刊论文  OAI收割 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017, 卷号: 20, 期号: 2, 页码: 133-139 作者:  Cheng, Jing;  Zheng, Guangyong;  Jin, Hai;  Gao, Xianfu;  ,   |  收藏  |  浏览/下载：36/0  |  提交时间：2020/12/09 ESCC  metabolomics  LC-MS/MS  tyrosine metabolism  diagnostic biomarker  prediction model   Metabolic research of domestically developed small molecule tyrosine kinase inhibitors 期刊论文  OAI收割 Acta Pharmaceutica Sinica, 2016, 卷号: 51, 期号: 2, 页码: 248-256 作者:  Jiang Jinfang;  Chen Xiaoyan;  Zhong Dafang   |  收藏  |  浏览/下载：31/0  |  提交时间：2019/01/08 tyrosine kinase inhibitor  in vivo metabolism  metabolic approach